Free Trial

Encompass Health (EHC) Earnings Date, Estimates & Call Transcripts

Encompass Health logo
$102.00 +0.88 (+0.87%)
(As of 11/25/2024 11:35 PM ET)

Encompass Health Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 5Estimated
Actual EPS
(Oct. 28)
$1.03 Beat By $0.09
Consensus EPS
(Oct. 28)
$0.94

Encompass Health posted Q3 2024 earnings on October 28, 2024, reporting an EPS of $1.03, which beat the consensus estimate of $0.94 by $0.09. Quarterly revenue rose 11.9% year-over-year to $1.35 billion, above the consensus estimate of $1.33 billion. With a trailing EPS of $4.14 and a P/E Ratio of 24.64, Encompass Health's earnings are expected to grow 10.96% next year, from $4.29 to $4.76 per share.

EHC Upcoming Earnings

Encompass Health's next earnings date is estimated for Wednesday, February 5, 2025, based off prior year's reporting schedules.

Get Encompass Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Encompass Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EHC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EHC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Encompass Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.91$0.91$0.91 
Q2 20243$0.96$1.01$0.98 
Q3 20243$0.90$0.92$0.91 
Q4 20243$0.98$1.07$1.01 
FY 202411$3.75$3.91$3.82 
Q1 20253$1.20$1.25$1.22 
Q2 20253$1.18$1.23$1.21 
Q3 20253$1.11$1.26$1.17 
Q4 20253$1.09$1.15$1.13 
FY 202512$4.58$4.89$4.73 
Q1 20261$1.35$1.35$1.35 
Q2 20261$1.41$1.41$1.41 
Q3 20261$1.24$1.24$1.24 

Encompass Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/5/2025
(Estimated)
------- 
10/28/2024Q3 2024$0.94$1.03+$0.09$1.00$1.33B$1.35B      
8/5/2024Q2 2024$1.01$1.11+$0.10$1.10$1.30B$1.30B          
4/24/2024Q1 2024$0.93$1.12+$0.19$1.14$1.27B$1.32B        
2/7/2024Q4 2023$0.83$0.95+$0.12$1.04$1.24B$1.25B    
10/27/2023Q3 2023$0.77$0.86+$0.09$0.88$1.19B$1.21B          
8/1/2023Q2 2023$0.74$0.95+$0.21$1.00$1.16B$1.19B          
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" (Ad)

What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?

Click here to see why experts and insiders may be preparing for the biggest financial crisis of the
4/28/2023Q1 2023$0.70$0.88+$0.18$0.89$1.14B$1.16B          
2/7/2023Q4 2022$0.85$0.88+$0.03$0.87$1.12B$1.14B    

Encompass Health Earnings - Frequently Asked Questions

Encompass Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates. Learn more on EHC's earnings history.

Encompass Health updated its FY 2024 earnings guidance on Monday, October, 28th. The company provided earnings per share guidance of 4.190-4.330 for the period, compared to the consensus EPS estimate of 4.190. The company issued revenue guidance of $5.3 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

In the previous quarter, Encompass Health (NYSE:EHC) reported $1.03 earnings per share (EPS) to beat the analysts' consensus estimate of $0.94 by $0.09. Learn more on analysts' earnings estimate vs. EHC's actual earnings.

The conference call for Encompass Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Encompass Health's latest earnings report can be read online.
Read Transcript

Encompass Health's earnings report can be found in their filing with the SEC.
View SEC filing

Encompass Health (NYSE:EHC) has a recorded annual revenue of $4.80 billion.

Encompass Health (NYSE:EHC) has a recorded net income of $352 million. EHC has generated $4.14 earnings per share over the last four quarters.

Encompass Health (NYSE:EHC) has a trailing price-to-earnings ratio of 24.64 and a forward price-to-earnings ratio of 23.78. The price/earnings-to-growth ratio is 1.34.

Encompass Health's earnings are expected to grow from $4.29 per share to $4.76 per share in the next year, which is a 10.96% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:EHC) was last updated on 11/26/2024 by MarketBeat.com Staff
From Our Partners